NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock?

NewAmsterdam Pharma Company N.V. (NAMS) shares ended the last trading session 5.9% higher at $32.48. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 13.6% gain over the past four weeks.The sudden rise in the stock price can be attributed to growing investor optimism regarding the potential of NewAmsterdam Pharma Company’s only investigational candidate, obicetrapib. The candidate is currently being studied as a pot ...